Den én gang daglige dosering er ikke evalueret hos patienter med nedsat leverfunktion: derfor bør den ordinerende læge foretage en omhyggelig individuel benefit/ risk- vurdering, ved ordination af CIALIS en gang dagligt.
Once-a-day dosing has not been evaluated in patients with hepatic impairment; therefore, if prescribed, a careful individual benefit/ risk evaluation should be undertaken by the prescribing physician.